Globus Medical, Inc.
GMED
$76.64
-$0.57-0.74%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.10B | 2.94B | 2.77B | 2.63B | 2.51B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.10B | 2.94B | 2.77B | 2.63B | 2.51B |
| Cost of Revenue | 977.59M | 938.87M | 900.36M | 924.71M | 941.98M |
| Gross Profit | 2.12B | 2.00B | 1.87B | 1.70B | 1.57B |
| SG&A Expenses | 1.19B | 1.14B | 1.08B | 1.04B | 974.72M |
| Depreciation & Amortization | 118.92M | 118.19M | 118.75M | 118.98M | 118.50M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.44B | 2.34B | 2.25B | 2.22B | 2.17B |
| Operating Income | 663.46M | 599.75M | 523.41M | 403.12M | 336.82M |
| Income Before Tax | 658.47M | 605.07M | 460.50M | 373.54M | 232.95M |
| Income Tax Expenses | 71.77M | 67.20M | 36.72M | 16.89M | 47.39M |
| Earnings from Continuing Operations | 586.71 | 537.87 | 423.78 | 356.65 | 185.56 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 586.71M | 537.87M | 423.78M | 356.65M | 185.56M |
| EBIT | 663.46M | 599.75M | 523.41M | 403.12M | 336.82M |
| EBITDA | 944.11M | 876.17M | 798.06M | 673.71M | 600.53M |
| EPS Basic | 4.35 | 3.98 | 3.13 | 2.63 | 1.36 |
| Normalized Basic EPS | 3.11 | 2.81 | 2.30 | 1.77 | 1.44 |
| EPS Diluted | 4.29 | 3.93 | 3.10 | 2.60 | 1.34 |
| Normalized Diluted EPS | 3.07 | 2.78 | 2.27 | 1.74 | 1.42 |
| Average Basic Shares Outstanding | 539.48M | 540.88M | 543.19M | 544.31M | 544.30M |
| Average Diluted Shares Outstanding | 546.66M | 548.24M | 551.38M | 554.05M | 554.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |